Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06516861
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-06-23
Brief Title:
Magnesium Sulphate and Lidocaine in Hemodynamic Changes and Cortisol Levels
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Comparison of Magnesium Sulphate 30 mgKg With Lidocaine 15 mgKg in Hemodynamic Changes and Cortisol Level Post-intubation in Patient Undergoing Craniotomy
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The sample was randomly divided into 3 groups consisting of patients who received Magnesium Sulfate 30 mgKg Lidocaine 15 mgKg and Control These groups will be checked for hemodynamic changes and cortisol values
Detailed Description:
The sample was randomly divided into 3 groups and divided into 3 groups consisting of patients who received Magnesium Sulfate 30 mgKg Lidocaine 15 mgKg and Control The first group of patients was given Magnesium Sulfate 30 mg kg diluted in 20 ml with NaCl 09 labeled with code A and given in 5 minutes with a syringe pump The second group was given Lidocaine 15 mgkg diluted in 20 ml with NaCl 09 labeled with code B and given in 5 minutes with a syringe pump The third group was given NaCl 09 in a 20 ml syringe labeled with code C and given in 5 minutes with a syringe pump After induction and intubation patients were then recorded systolic blood pressure diastolic blood pressure MAP and pulse at T1 3 minutes T2 5 minutes T3 7 minutes and T4 10 minutes
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None